Emma K. Link
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial.
Journal: The Lancet. Oncology
Published: February 13, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study.
Journal: British journal of clinical pharmacology
Published: May 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2025
Node-positive carcinoma of the vulva treated with curative-intent radiotherapy.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 19, 2024
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial.
Journal: European urology oncology
Published: July 20, 2024
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
Journal: Lancet (London, England)
Published: November 01, 2022
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2022
A phase 1 clinical trial of the repurposable acetyllysine mimetic, n-methyl-2-pyrrolidone (NMP), in relapsed or refractory multiple myeloma.
Journal: Clinical epigenetics
Published: September 25, 2022
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Journal: Lancet (London, England)
Published: December 21, 2021
Increased risk of diaphragmatic herniation following esophagectomy with a minimally invasive abdominal approach.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: June 24, 2021
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.
Journal: European journal of clinical pharmacology
Published: April 14, 2021
Last Updated: 09/26/2026